• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: NXSTAGE MEDICAL, INC. NXSTAGE SYSTEM ONE; HIGH PERMEABILITY HEMODIALYSIS SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

NXSTAGE MEDICAL, INC. NXSTAGE SYSTEM ONE; HIGH PERMEABILITY HEMODIALYSIS SYSTEM Back to Search Results
Model Number SAK-403
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Fever (1858); Headache (1880); Low Blood Pressure/ Hypotension (1914); Unspecified Infection (1930); Tachycardia (2095); Tingling (2171); Chills (2191); Numbness (2415); Lethargy (2560)
Event Date 04/12/2019
Event Type  Injury  
Manufacturer Narrative
A review of the device history record (dhr) for the involved dialysate sack lot was conducted which confirmed the product met all quality criteria and manufacturing specifications prior to release.There is no evidence to suggest that a product malfunction occurred.The user guide provides instruction to maintain aseptic technique and warnings to follow instructions provided to prevent the risk of exposure to infectious diseases.Biocompatibility of the device has been established.Nxstage medical considers this report closed.No additional information will be provided.
 
Event Description
A report was received on (b)(6) 2019 from the home therapy nurse (htn) of a (b)(6) male with multiple comorbidities including end-stage renal disease (esrd) and elevated liver function tests (lft), who experienced headache, fever (104.5 f), tachycardia (117 bpm), numbness/tingling in his fingers, lower back pain, chills, hypotension (98/58), and increased lethargy approximately 50 minutes after initiating his first in-center hemodialysis treatment with the dialysate sack on (b)(6) 2019.Therapy was terminated, intravenous (iv) vancomycin (1.5g) & ceftazidime (1.5g) were administered, and the patient become unresponsive.Nasal oxygen (o2) was applied, and the patient was transported via ambulance and admitted to the intensive care unit (icu).Additional information received on (b)(6) 2019 from the htn revealed that evaluation in hospital included blood and stool cultures with no organism identified.Viral syndrome was suspected, and the iv antibiotics were ceased.Further blood tests, electrocardiogram (ekg) and chest x-ray (cxr) revealed no causative factors.The patient received a diagnosis of sepsis with acute organ dysfunction and was discharged in stable condition on (b)(6) 2019.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
NXSTAGE SYSTEM ONE
Type of Device
HIGH PERMEABILITY HEMODIALYSIS SYSTEM
Manufacturer (Section D)
NXSTAGE MEDICAL, INC.
350 merrimack street
lawrence MA 01843
Manufacturer (Section G)
MEDIMEXICO S. DE R. L. DE C. V
av. valle imperial no. 10523
parque industrial valle sur
tijuana 22180
MX   22180
Manufacturer Contact
paula rogalski
nxstage medical, inc
350 merrimack street
lawrence, MA 01843
9784505276
MDR Report Key8579662
MDR Text Key144122579
Report Number3003464075-2019-00014
Device Sequence Number1
Product Code FKR
UDI-Device IdentifierM535SAK4030
UDI-Public+M535SAK4030/$$1220901792854
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
K140571
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Nurse
Type of Report Initial
Report Date 01/01/2005,05/03/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/03/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date12/16/2020
Device Model NumberSAK-403
Device Catalogue NumberSAK-403
Device Lot Number90179285
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Date Manufacturer Received04/17/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age28 YR
-
-